The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $125.16 million. The enterprise value is $102.47 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
The Joint has 15.34 million shares outstanding. The number of shares has increased by 2.00% in one year.
| Current Share Class | 15.34M |
| Shares Outstanding | 15.34M |
| Shares Change (YoY) | +2.00% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 3.44% |
| Owned by Institutions (%) | 45.48% |
| Float | 10.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 16.16 |
| PS Ratio | 2.40 |
| Forward PS | 2.20 |
| PB Ratio | 5.59 |
| P/TBV Ratio | 5.60 |
| P/FCF Ratio | 38.48 |
| P/OCF Ratio | 27.41 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 30.30 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.09.
| Current Ratio | 1.80 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.64 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -3.97% and return on invested capital (ROIC) is -1.47%.
| Return on Equity (ROE) | -3.97% |
| Return on Assets (ROA) | -0.59% |
| Return on Invested Capital (ROIC) | -1.47% |
| Return on Capital Employed (ROCE) | -1.96% |
| Revenue Per Employee | $72,622 |
| Profits Per Employee | -$6,548 |
| Employee Count | 736 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $67,185 in taxes.
| Income Tax | 67,185 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.97% in the last 52 weeks. The beta is 1.45, so The Joint's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | -21.97% |
| 50-Day Moving Average | 10.22 |
| 200-Day Moving Average | 10.84 |
| Relative Strength Index (RSI) | 19.75 |
| Average Volume (20 Days) | 99,828 |
Short Selling Information
The latest short interest is 606,334, so 3.95% of the outstanding shares have been sold short.
| Short Interest | 606,334 |
| Short Previous Month | 548,281 |
| Short % of Shares Out | 3.95% |
| Short % of Float | 6.00% |
| Short Ratio (days to cover) | 6.77 |
Income Statement
In the last 12 months, The Joint had revenue of $53.45 million and -$4.82 million in losses. Loss per share was -$0.32.
| Revenue | 53.45M |
| Gross Profit | 41.71M |
| Operating Income | -738,488 |
| Pretax Income | -856,441 |
| Net Income | -4.82M |
| EBITDA | -1.50M |
| EBIT | -738,488 |
| Loss Per Share | -$0.32 |
Full Income StatementBalance Sheet
The company has $29.81 million in cash and $2.17 million in debt, giving a net cash position of $27.64 million or $1.80 per share.
| Cash & Cash Equivalents | 29.81M |
| Total Debt | 2.17M |
| Net Cash | 27.64M |
| Net Cash Per Share | $1.80 |
| Equity (Book Value) | 23.26M |
| Book Value Per Share | 1.52 |
| Working Capital | 28.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.75 million and capital expenditures -$1.36 million, giving a free cash flow of $3.38 million.
| Operating Cash Flow | 4.75M |
| Capital Expenditures | -1.36M |
| Free Cash Flow | 3.38M |
| FCF Per Share | $0.22 |
Full Cash Flow StatementMargins
Gross margin is 78.03%, with operating and profit margins of -1.38% and -9.02%.
| Gross Margin | 78.03% |
| Operating Margin | -1.38% |
| Pretax Margin | -1.60% |
| Profit Margin | -9.02% |
| EBITDA Margin | -2.80% |
| EBIT Margin | -1.38% |
| FCF Margin | 6.33% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.00% |
| Shareholder Yield | -2.00% |
| Earnings Yield | -3.70% |
| FCF Yield | 2.60% |
Analyst Forecast
The average price target for The Joint is $16.33, which is 100.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.33 |
| Price Target Difference | 100.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
The Joint has an Altman Z-Score of 2.71 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.71 |
| Piotroski F-Score | 5 |
